CERAMAX CERAMIC HIP SYSTEM
Depuy Orthopaedics, Inc. · Decision date Sep 4, 2026
What did the FDA decide?
The FDA record for P070026/S129 describes a 30-day notice for the Ceramax Ceramic Hip System, submitted by DePuy Orthopaedics, Inc. The stated change is "the addition of an alternate component forging supplier for business continuity purposes," filed under the supplement reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier." The device category is a semi-constrained hip prosthesis with metal/ceramic/ceramic/metal bearing surfaces, cemented or uncemented, product code MRA.
The identifier links this notice to the original PMA P070026; the S129 supplement is a manufacturing-supplier change, not an approval of the whole system. The record states a business-continuity purpose for adding the forging supplier. It does not identify the supplier, the component affected, or any validation data, and it supplies no evidence on safety or clinical performance. Whether the alternate forging source was accepted or how it compares to the existing source remains absent from the supplied fields.
Because the statement is limited to that purpose, the record shows regulatory filing activity only. It should not be read as a new indication, a clinical finding, or proof that the alternate-supplied components perform comparably. The supplied fields give no trial, benefit, or outcome information beyond the change description.
FDA approval order statement
the addition of an alternate component forging supplier for business continuity purposes.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 4, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P070026/S129
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- MRA
- Decision code
- OK30
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented.
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- MRA
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P070026. Subsequent supplements may change the device or its indications.
FDA decision timeline
P070026 · Original PMA
CERAMAX CERAMIC HIP SYSTEM
P070026/S122 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
P070026/S121 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
P070026/S123 · Related supplement
Ceramax Ceramic Hip System
P070026/S118 · Related supplement
Ceramax Ceramic Total Hip System
P070026/S124 · Related supplement
Ceramax Ceramic Hip System
P070026/S125 · Related supplement
Ceramax Ceramic Hip System
P070026/S127 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
P070026/S128 · Related supplement
CERAMAX Ceramic Total Hip System
P070026/S129 received
Application receipt date recorded by FDA.
P070026/S130 · Related supplement
CERAMAX Ceramic Hip System
P070026/S129 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P070026. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P070026
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CERAMAX CERAMIC HIP SYSTEMP070026 | Depuy Orthopaedics, Inc. | PMA approval | Dec 23, 2010 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S122 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 1, 2025 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S121 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 5, 2025 | FDA |
Ceramax Ceramic Hip SystemP070026/S123 | Depuy Orthopaedics, Inc. | PMA supplement | Dec 9, 2025 | FDA |
Ceramax Ceramic Total Hip SystemP070026/S118 | Depuy Orthopaedics, Inc. | PMA supplement | Jan 8, 2026 | FDA |
Ceramax Ceramic Hip SystemP070026/S124 | Depuy Orthopaedics, Inc. | PMA supplement | Apr 10, 2026 | FDA |
Ceramax Ceramic Hip SystemP070026/S125 | Depuy Orthopaedics, Inc. | PMA supplement | Apr 29, 2026 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S127 | Depuy Orthopaedics, Inc. | PMA supplement | Jun 3, 2026 | FDA |
CERAMAX Ceramic Total Hip SystemP070026/S128 | Depuy Orthopaedics, Inc. | PMA supplement | Jul 24, 2026 | FDA |
CERAMAX Ceramic Hip SystemP070026/S130 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 27, 2026 | FDA |
Explore the linked device profile
Other records with product code MRA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| HOWMEDICA OSTEONICS CORP | PMA supplement | Sep 17, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy Orthopaedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 700 Orthopaedic Dr., Warsaw, IN, 46582
Sources and methodology
- Original FDA record: P070026/S129
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





